New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2

被引：0
|
作者：
Sohn, S. K.
Chae, Y. S.
Kim, J. G.
Cho, Y. Y.
Moon, J. H.
Shin, H. J.
Chung, J. S.
Cho, G. J.
Yang, D. H.
Lee, J. J.
Kim, Y. K.
Kim, H. J.
机构：
[1] Kyungpook Natl Univ Hosp, Taegu, South Korea
[2] Pusan Natl Univ Hosp, Pusan, South Korea
[3] Chonnam Natl Univ Hosp, Kwangju, South Korea
来源：
BONE MARROW TRANSPLANTATION | 2007年 / 39卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S203 / S204
页数：2
相关论文
共 50 条
  • [1] New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2
    Chae, Y. S.
    Sohn, S. K.
    Kim, J. G.
    Cho, Y. Y.
    Moon, J. H.
    Shin, H. J.
    Chung, J. S.
    Cho, G. J.
    Yang, D. H.
    Lee, J-J
    Kim, Y-K
    Kim, H-J
    BONE MARROW TRANSPLANTATION, 2007, 40 (06) : 541 - 547
  • [2] New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2
    Y S Chae
    S K Sohn
    J G Kim
    Y Y Cho
    J H Moon
    H J Shin
    J S Chung
    G J Cho
    D H Yang
    J-J Lee
    Y-K Kim
    H-J Kim
    Bone Marrow Transplantation, 2007, 40 : 541 - 547
  • [3] Fludarabine and busulfan as conditioning regimen in allogeneic stem cell transplantation: comparison with BuCy2
    Fedele, R.
    Moscato, T.
    Massara, E.
    Messina, G.
    Iacopino, O.
    Pontari, A.
    Spiniello, E.
    Callea, I.
    Garreffa, C.
    Martino, M.
    Console, G.
    Gallo, G.
    Princi, D.
    Monteleone, R.
    Irrera, G.
    Iacopino, P.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S418 - S419
  • [4] Comparison of BuCy (Busulfan plus Cyclophosphamide) Versus FluBu4 (Fludarabine plus Busulfan) As a Conditioning Regimen for Allogeneic Stem Cell Transplantation
    Park, Silvia
    Hong, Jung Yong
    Choi, Moon Ki
    Kim, Young Saing
    Lee, Ji Yun
    Lim, Sung Hee
    Jung, Chul Won
    Jang, Jun Ho
    Kim, Kihyun
    BLOOD, 2012, 120 (21)
  • [5] Comparison Between Busulfan with Cyclophosphamide and Busulfan with Fludarabine As Myeloablative Conditioning of Allogeneic Hematopoietic Stem Cell Transplantation for Myeloid Malignancies
    Mori, Takehiko
    Ohashi, Kazuteru
    Kanamori, Heiwa
    Sakura, Toru
    Yano, Shingo
    Kanda, Yoshinobu
    Kako, Shinichi
    Tachibana, Takayoshi
    Yokota, Akira
    Onizuka, Makoto
    Nakaseko, Chiaki
    Okamoto, Shinichiro
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S204 - S204
  • [6] Efficacy of treosulfan in combination with fludarabine as conditioning regimen in allogeneic transplantation as compared with a myeloablative conditioning using busulfan and fludarabine
    Calvo Sanchez, J. A.
    Fernandez Garcia, S.
    Aranguren del Castillo, L.
    Fernandez-Luis, S.
    Yanez San Segundo, L.
    Insunza Gaminde, A.
    Fernandez Escalada, N.
    Martin Sanchez, G.
    Colorado Araujo, M. M.
    Lopez Duarte, M.
    Sanchez Escamilla, M.
    Montes Gaisan, C.
    Romon Alonso, J. I.
    Arroyo Rodriguez, J. L.
    Ocio San Miguel, E. M.
    Bermudez Rodriguez, M. A.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 166 - 167
  • [7] COMPARISON OF IV BUSULFAN AND FLUDARABINE VS IV BUSULFAN AND CYCLOPHOSPHAMIDE AS CONDITIONING REGIMEN IN MYELOABALTIVE ALLOGENEIC STEM CELL TRANSPLANTATION
    de Villambrosia, S. Gonzalez
    Moreto, A.
    Nunez, J.
    Bermudez, A.
    Yanez, L.
    Insunza, A.
    Iriondo, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 142 - 142
  • [8] A Comparison of the Myeloablative Conditioning Regimen Fludarabine/Busulfan with Cyclophosphamide/Total Body Irradiation, for Allogeneic Stem Cell Transplantation in the Modern Era: A Cohort Analysis
    Gooptu, Mahasweta
    Kim, Haesook T.
    Ho, Vincent T.
    Alyea, Edwin P.
    Koreth, John
    Armand, Philippe
    Ritz, Jerome
    Nikiforow, Sarah
    Glotzbecker, Brett E.
    Nageshwar, Prashant
    Soiffer, Robert J.
    Antin, Joseph H.
    Cutler, Corey S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (08) : 1733 - 1740
  • [9] Fludarabine and busulfan as a reduced-toxicity myeloablative conditioning regimen in allogeneic hematopoietic stem cell transplantation for acute leukemia patients
    Dai, Zhiming
    Liu, Jie
    Zhang, Wang-Gang
    Cao, Xingmei
    Zhang, Yang
    Dai, Zhijun
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 4 (04) : 667 - 671
  • [10] Fludarabine and busulfan as a myeloablative conditioning regimen for allogeneic stem cell transplantation in high- and standard-risk leukemic patients
    Iravani, M.
    Evazi, M. R.
    Mousavi, S. A.
    Shamshiri, A. R.
    Tavakoli, M.
    Ashouri, A.
    Samiee, S.
    Chahardovali, B.
    Alimoghaddam, K.
    Ghaffari, S. H.
    Ghavamzadeh, A.
    BONE MARROW TRANSPLANTATION, 2007, 40 (02) : 105 - 110
12345